Literature DB >> 23546801

Arterial vascular cell line expressing SSAO: a new tool to study the pathophysiology of vascular amine oxidases.

Kaleem Ullah1, Bingjie Xie, Javed Iqbal, Aamir Rasool, Hong Qing, Yulin Deng.   

Abstract

Semicarbazide-sensitive amine oxidase (SSAO) widely exists in nature, mainly expressed at significant levels in vasculature. It plays a detrimental role in vascular diseases, particularly atherosclerosis, which occurs mainly in arteries. Herein we for the first time present SSAO expression in arterial lineage of vascular cell line, i.e., human umbilical arterial endothelial cell (HUAEC). Firstly, two commercially available gene transfection reagents were compared to determine high transfection efficiency and then the expression behavior of HUAEC:SSAO was characterized. Furthermore, our model was also been compared with commonly used human embryonic kidney (HEK) cell transfected with the same vector. For enzymatic assay, an in-house developed highly sensitive high performance liquid chromatography electron spray ionization mass spectrometry method was applied. Results indicated that the maximal transfection efficiency in HUAEC was detected by JetPEI™ and transfected protein was expressed at membrane and cytosol of different clones. No significant variations were observed in HUAEC between cell passages 1 and 7, although HEK cell displayed twofold higher SSAO expression level than HUAEC. The transfected SSAO was shown to be released into the cell-culture medium. Both cellular and released types of SSAO exhibited monomer and dimer structural forms. The cytotoxicity determination exhibited large number of viable cells after transfection with JetPEI™. Differential expression characterization of this new cell line demonstrates the correct behavior of SSAO in arterial endothelial cells and also provides a real physiological environment to elucidate the unclear role of this enzyme. In addition, our cellular model could partly solve the problems raised by the loss of enzyme expression found in cultured endothelial cells. This model could also be a useful tool for proteomic base study, screening of interacting protein and analysis of compounds that could modify its activity for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546801     DOI: 10.1007/s00702-013-1015-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  27 in total

1.  Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.

Authors:  Mar Hernandez-Guillamon; Lidia Garcia-Bonilla; Montse Solé; Victoria Sosti; Mireia Parés; Mireia Campos; Arantxa Ortega-Aznar; Carmen Domínguez; Marta Rubiera; Marc Ribó; Manolo Quintana; Carlos A Molina; José Alvarez-Sabín; Anna Rosell; Mercedes Unzeta; Joan Montaner
Journal:  Stroke       Date:  2010-06-10       Impact factor: 7.914

Review 2.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

Authors:  Mark A Creager; Thomas F Lüscher; Francesco Cosentino; Joshua A Beckman
Journal:  Circulation       Date:  2003-09-23       Impact factor: 29.690

Review 3.  A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.

Authors:  Theodora Szasz; Keshari Thakali; Gregory D Fink; Stephanie W Watts
Journal:  Exp Biol Med (Maywood)       Date:  2007-01

4.  Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.

Authors:  Montse Solé; Mercedes Unzeta
Journal:  Biol Cell       Date:  2011-11       Impact factor: 4.458

5.  Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis.

Authors:  Z Mészáros; I Karádi; A Csányi; T Szombathy; L Romics; K Magyar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.441

6.  Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.

Authors:  S D Langford; M B Trent; A Balakumaran; P J Boor
Journal:  Toxicol Appl Pharmacol       Date:  1999-03-15       Impact factor: 4.219

7.  A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles.

Authors:  Teresa Mateo; Yafa Naim Abu Nabah; Mercedes Losada; Rossana Estellés; Chantal Company; Begoña Bedrina; Jose Miguel Cerdá-Nicolás; Stephen Poole; Peter J Jose; Julio Cortijo; Esteban J Morcillo; Maria-Jesus Sanz
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

8.  Origins of serum semicarbazide-sensitive amine oxidase.

Authors:  Craig M Stolen; Gennady G Yegutkin; Riikka Kurkijärvi; Petri Bono; Kari Alitalo; Sirpa Jalkanen
Journal:  Circ Res       Date:  2004-06-03       Impact factor: 17.367

9.  Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin.

Authors:  F Boomsma; F H Derkx; A H van den Meiracker; A J Man in 't Veld; M A Schalekamp
Journal:  Clin Sci (Lond)       Date:  1995-06       Impact factor: 6.124

Review 10.  Experimental models for assaying microvascular endothelial cell pathophysiology in stroke.

Authors:  Susanna Camós; Judith Mallolas
Journal:  Molecules       Date:  2010-12-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.